rs151329289
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_020717.5(SHROOM4):c.1675G>A(p.Glu559Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000519 in 1,209,155 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 212 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020717.5 missense
Scores
Clinical Significance
Conservation
Publications
- X-linked intellectual disability, Stocco dos Santos typeInheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- complex neurodevelopmental disorderInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SHROOM4 | NM_020717.5 | c.1675G>A | p.Glu559Lys | missense_variant | Exon 4 of 9 | ENST00000376020.9 | NP_065768.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SHROOM4 | ENST00000376020.9 | c.1675G>A | p.Glu559Lys | missense_variant | Exon 4 of 9 | 2 | NM_020717.5 | ENSP00000365188.2 | ||
| SHROOM4 | ENST00000289292.11 | c.1675G>A | p.Glu559Lys | missense_variant | Exon 4 of 10 | 1 | ENSP00000289292.7 | |||
| SHROOM4 | ENST00000460112.3 | c.1327G>A | p.Glu443Lys | missense_variant | Exon 3 of 8 | 5 | ENSP00000421450.1 |
Frequencies
GnomAD3 genomes AF: 0.000386 AC: 43AN: 111437Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000315 AC: 57AN: 180846 AF XY: 0.000244 show subpopulations
GnomAD4 exome AF: 0.000533 AC: 585AN: 1097663Hom.: 0 Cov.: 33 AF XY: 0.000559 AC XY: 203AN XY: 363039 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000386 AC: 43AN: 111492Hom.: 0 Cov.: 22 AF XY: 0.000267 AC XY: 9AN XY: 33688 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
SHROOM4: BP4, BS2 -
- -
- -
not specified Uncertain:2
- -
The c.1675G>A (p.E559K) alteration is located in exon 4 (coding exon 4) of the SHROOM4 gene. This alteration results from a G to A substitution at nucleotide position 1675, causing the glutamic acid (E) at amino acid position 559 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at